Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Neuralink builds implantable brain-computer interfaces that let people control computers with their thoughts.
Neuralink is a medical device company trying to build a wireless brain implant that connects the human brain directly to a computer. The idea sounds like science fiction, but the goal is practical: help people who have lost control of their bodies, like patients with paralysis, use a phone, a cursor, or a robotic arm just by thinking. The device, called a brain-computer interface, is a small chip with tiny threads that a surgical robot stitches into the brain's motor cortex. Those threads pick up electrical signals from neurons, and software translates the signals into digital commands.
The company is still pre-revenue in any meaningful commercial sense. It has no product on the market and earns nothing from sales today; its funding comes from investors and from Elon Musk, who co-founded it in 2016 and remains its most visible backer. Neuralink's first push is a clinical trial program called PRIME, aimed at people with paralysis. In early 2024 it implanted its first device in a human patient, who later used it to move a computer cursor and play online chess. A second patient followed later that year. These are early, carefully watched milestones, not a business yet. The science is genuinely hard, and the competition is real. Rivals like Synchron are testing a different, less invasive approach that threads a device through blood vessels rather than cutting into the skull. Neuralink's advantage is ambition and engineering depth: more electrodes, a custom surgical robot, and tight vertical integration of hardware and software. Its biggest risks are equally large. Brain surgery carries infection and bleeding risk, long-term electrode durability is unproven, and regulators at the FDA watch every step closely. The company has also drawn criticism over animal testing practices and workplace culture.
The money question is the interesting one. Neuralink has raised hundreds of millions of dollars from venture investors and reportedly reached a valuation in the billions, though it has no revenue to justify that figure yet — it is a bet on a future market for brain implants. If the trials keep working, the first customers will be medical: patients, insurers, and hospitals paying for a treatment that restores lost function. Musk has talked much more grandly about healthy people eventually using implants to merge with AI, but that is a vision, not a business plan. For now, Neuralink is a very expensive, very public research project with a real chance to change medicine and a real chance to stumble.
Saved answer · last researched 4 Nov 2026